- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Events
Page 134
Instacart aims for IPO at $30bn valuation
The Amazon, Comcast and American Express-backed grocery delivery service is reportedly looking at early next year for an offering that would hike its valuation 70%.
Nov 13, 2020Pkware picks up Dataguise
Samsung Next's data security portfolio company Dataguise has been acquired after raising moe than $20m in funding since 2007.
Nov 13, 2020Snap grabs Voca.ai in $70m acquisition
The voice analytics software provider has reportedly been bought by Snap after raising about $6m from investors including American Express Ventures.
Nov 13, 2020Silverback goes for IPO gold
The cancer immunothrapy developer has filed to raise up to $100m in an offering that will follow $211m from backers including Celgene and Bristol-Myers Squibb.
Nov 12, 2020Brown & Brown gives CoverHound a home
The acquisition of insurance marketplace CoverHound comes after $112m in funding from investors including Hiscox, Chubb, MS&AD, Aflac Ventures, Ace Group and American Family Ventures.
Nov 11, 2020Adobe to administer $1.5bn Workfront acquisition
Susquehanna International Group is set to exit the marketing collaboration software developer having invested just over a year ago.
Nov 10, 2020ShopKeep reaches Lightspeed in $440m deal
First Data and Salesforce Ventures are set to exit the digital commerce technology provider after it agreed to be purchased for $440m in cash and stock.
Nov 9, 2020Analysis: Ant in the balance
China-based financial services provider Ant Group, spun off by e-commerce group Alibaba, intended to float on the Shanghai and Hong Kong stock markets.
Nov 9, 2020Kuaishou broadcasts IPO filing
The Baidu and Tencent-backed video streaming platform developer has filed for a Hong Kong offering that could potentially value it at $50bn.
Nov 6, 2020Merck & Co marks $2.75bn VelosBio purchase
Takeda Ventures and Chiesi Ventures are set to exit the cancer drug developer through the deal, which came after just over $200m in funding.
Nov 6, 2020About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


